12-Month efficacy and safety of OROS® MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPH

Category Primary study
JournalEuropean Child and Adolescent Psychiatry, Supplement
Year 2005
This article has no abstract
Epistemonikos ID: 83f05ab499ef0f3a3bd3e8691d53207bdc118357
First added on: Feb 04, 2025